Balyasny Asset Management LLC Editas Medicine, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 174,035 shares of EDIT stock, worth $208,842. This represents 0.0% of its overall portfolio holdings.

Number of Shares

174,035

Previous 37,967 358.38%

Holding current value

$208,842

Previous $177,000 235.03%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.39 - $5.96 $461,270 - $810,965	136,068 Added 358.38%	174,035 $593,000
Q2 2024 Aug 14, 2024	SELL	$4.67 - $7.28 $1.19 Million - $1.85 Million	-254,743 Reduced 87.03%	37,967 $177,000
Q1 2024 May 13, 2024	BUY	$7.03 - $11.07 $1.64 Million - $2.58 Million	233,387 Added 393.42%	292,710 $2.17 Million
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $370,768 - $659,078	59,323 New	59,323 $600,000
Q4 2022 Feb 14, 2023	BUY	$8.32 - $13.21 $2.17 Million - $3.44 Million	260,737 Added 306.02%	345,940 $3.07 Million
Q3 2022 Nov 14, 2022	SELL	$12.16 - $19.42 $2.79 Million - $4.45 Million	-229,044 Reduced 72.89%	85,203 $1.04 Million
Q2 2022 Aug 15, 2022	BUY	$9.99 - $21.35 $3.14 Million - $6.71 Million	314,247 New	314,247 $3.72 Million
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $1.17 Million - $2.18 Million	-29,902 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $935,633 - $1.69 Million	29,902 New	29,902 $1.69 Million
Q3 2019 Nov 14, 2019	SELL	$22.49 - $26.81 $2.68 Million - $3.19 Million	-118,993 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$20.48 - $27.76 $1.85 Million - $2.5 Million	90,126 Added 312.21%	118,993 $2.94 Million
Q1 2019 May 15, 2019	SELL	$19.43 - $26.41 $198,127 - $269,302	-10,197 Reduced 26.1%	28,867 $706,000
Q4 2018 Feb 14, 2019	BUY	$18.19 - $31.79 $710,574 - $1.24 Million	39,064 New	39,064 $889,000
Q3 2018 Nov 14, 2018	SELL	$27.65 - $38.39 $273,182 - $379,293	-9,880 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$31.4 - $41.01 $526,295 - $687,368	-16,761 Reduced 62.91%	9,880 $354,000
Q1 2018 May 15, 2018	BUY	$29.84 - $44.08 $794,967 - $1.17 Million	26,641 New	26,641 $883,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $82.5M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Editas Medicine, Inc. Transaction History